SCYNEXIS, Inc. (SCYX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:06AM EDT. Market open.
| Previous close | 1.8200 |
| Open | 1.7900 |
| Bid | 1.6800 x 400 |
| Ask | 1.8000 x 300 |
| Day's range | 1.7200 - 1.8000 |
| 52-week range | 1.3500 - 3.8700 |
| Volume | |
| Avg. volume | 207,430 |
| Market cap | 65.691M |
| Beta (5Y monthly) | 1.57 |
| PE ratio (TTM) | 1.25 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Shareholders in SCYNEXIS (NASDAQ:SCYX) are in the red if they invested five years ago
We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits...
- Insider Monkey
11 Cheapest Stocks With Biggest Upside
In this piece, we will take a look at the 11 cheapest stocks with the biggest upside. If you want to skip our introduction to stock valuation and recent market news, then take a look at 5 Cheapest Stocks With Biggest Upside. Identifying the right stocks to invest in is a science that involves evaluating […]
- Zacks
Verve Therapeutics (VERV) Soars 13.8%: Is Further Upside Left in the Stock?
Verve Therapeutics (VERV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
© 2024 Yahoo. All rights reserved.